ArticleBlood2014
Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England.
Article in Blood, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.
- Pre-Existing and Gestational Diabetes and Risk of Maternal Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies.BJOG : an international journal of obstetrics and gynaecology · 2025Pooled it
- Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research.Health technology assessment (Winchester, England) · 2024Pooled it
- Maternal age and pregnancy-related cardiovascular complications.Nature communications · 2026Article
- SARS-CoV-2 infection in pregnant women and incidence of thromboembolic disease: an analysis of the Covid-19-Related Obstetric and Neonatal Outcome Study (CRONOS) in Germany.Archives of gynecology and obstetrics · 2025Observational
- Low-molecular-weight heparins utilization in pregnant and postpartum women: a real-world analysis in China (2016-2021).Frontiers in pharmacology · 2025Article
- Article
- Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis.Research and practice in thrombosis and haemostasis · 2024Review
- Rationale for the Potential Use of Recombinant Activated Factor VII in Severe Post-Partum Hemorrhage.Journal of clinical medicine · 2024Article
- Use of the RCOG risk assessment model and biomarkers to evaluate the risk of postpartum venous thromboembolism.Thrombosis journal · 2023Article
- Management of Postpartum Extensive Venous Thrombosis after Second Pregnancy.Medicina (Kaunas, Lithuania) · 2023Article
- Management of obesity across women's life course: FIGO Best Practice Advice.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2023Article
- Agreement between two scales used for assessing risk classification for thromboembolic events and the requirement of postpartum pharmacological prophylaxisRevista colombiana de obstetricia y ginecologia · 2022Article
- Association Between Maternal Weight Gain in Different Periods of Pregnancy and the Risk of Venous Thromboembolism: A Retrospective Case-Control Study.Frontiers in endocrinology · 2022Article
- Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review.Frontiers in cardiovascular medicine · 2022Review
- The Risk of Thrombosis Around Pregnancy: Where Do We Stand?Frontiers in cardiovascular medicine · 2022Article
- Evaluation of CTPA interpreted as limited in pregnant patients suspected for pulmonary embolism.Emergency radiology · 2020Article
- Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism.Hypertension (Dallas, Tex. : 1979) · 2020Article
- Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement.Blood transfusion = Trasfusione del sangue · 2019Article
- Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean section.International journal of clinical pharmacy · 2019Article
- Identification of Genetic Interaction with Risk Factors Using a Time-To-Event Model.International journal of environmental research and public health · 2017Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Impact on the timing of first postpartum venous thromboembolism (VTE) for women with specific risk factors is of crucial importance when planning the duration of thromboprophylaxis regimen. We observed this using a large linked primary and secondary care database containing 222 334 pregnancies resulting in live and stillbirth births between 1997 and 2010. We assessed the impact of risk factors on the timing of postpartum VTE in term of absolute rates (ARs) and incidence rate ratios (IRRs) using a Poisson regression model. Women with preeclampsia/eclampsia and postpartum acute systemic infection had the highest risk of VTE during the first 3 weeks postpartum (ARs ≥2263/100 000 person-years; IRR ≥2.5) and at 4-6 weeks postpartum (AR ≥1360; IRR ≥3.5). Women with body mass index (BMI) >30 kg/m(2) or those having cesarean delivery also had elevated rates up to 6 weeks (AR ≥1425 at 1-3 weeks and ≥722 at 4-6 weeks). Women with postpartum hemorrhage or preterm birth, had significantly increased VTE rates only in the first 3 weeks (AR ≥1736; IRR ≥2). Our findings suggest that the duration of the increased VTE risk after childbirth varies based on the type of risk factors and can extend up to the first 3 to 6 weeks postpartum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.